Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
321.09
-9.50 (-2.87%)
Mar 3, 2026, 2:52 PM EST - Market open

PRAX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-303.27-182.82-123.28-214.03-167.06
Depreciation & Amortization
0.140.360.430.420.18
Loss (Gain) From Sale of Investments
-3.59-5.010.0512.09
Stock-Based Compensation
33.9441.3624.8628.5922.69
Other Operating Activities
1.033.430.840.751.41
Change in Accounts Payable
12.16.71-8.863.897.27
Change in Unearned Revenue
--2.55-2.455-
Change in Other Net Operating Assets
10.586.76-2.73-10.678.87
Operating Cash Flow
-249.07-131.76-111.14-185.04-124.55
Capital Expenditures
-0.06--0.05-0.44-1.05
Investment in Securities
-311.09-248.493997.33-139.47
Investing Cash Flow
-311.15-248.4938.9596.89-140.52
Issuance of Common Stock
704.26514.6392.0110.99108.16
Repurchase of Common Stock
-2.09-0.31-0.14-0.26-
Other Financing Activities
----0.26-0.58
Financing Cash Flow
702.17514.3291.8710.47107.59
Net Cash Flow
141.96134.0719.69-77.69-157.49
Free Cash Flow
-249.12-131.76-111.19-185.49-125.6
Free Cash Flow Margin
--1540.48%-4543.77%--
Free Cash Flow Per Share
-11.07-7.36-16.86-60.36-44.38
Levered Free Cash Flow
-146.25-69.94-65.69-108.31-65.87
Unlevered Free Cash Flow
-146.25-69.94-65.69-108.31-65.87
Change in Working Capital
22.6810.92-14.03-1.7816.13
Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q